Discordant dMMR/IHC Status Correlates With Improved Treatment Outcomes in CRC and Endometrial Cancer

home / oncclub / discordant-dmmr-ihc-status-correlates-with-improved-treatment-outcomes-in-crc-and-endometrial

Amin Nassar, MD, and Elias Bou Farhat, MD, discuss data from a retrospective study that examined whether next-generation sequencing could be utilized alongside standard immunohistochemistry to detect mismatch repair deficiency that might otherwise be missed in patients with colorectal cancer or endometrial cancer.